scorecardresearch
Follow Us:
Tuesday, March 09, 2021

DCGI

DCGI NEWS

Don’t to be misguided by rumours, government ready for Covid vaccine roll out: Gujarat CM

January 11, 2021 4:26 am

In the first round of vaccination, nearly 11 lakh health workers and other frontline workers, who were directly involved in Covid-19 management, will be inoculated, the CM said through a video message on a social media platform.

Vardhan reviews preparedness for Covid vaccination trial run on January 2

January 01, 2021 10:08 pm

Vardhan asked officials concerned to ensure that the vaccination sites and official in-charge abide by the detailed checklist and SOP for vaccination that has been prepared by the health ministry and shared with the states/UTs to guide them in the dry run.

In-principle nod to replace gelatin in medicine capsules

July 26, 2015 2:52 am

The Indian Express had reported about the BIS notification and the scheduled meeting of the scientific committee July 24.

New drug capsule shells offer new choice: veg or non-veg

July 24, 2015 6:16 am

Expert panel to meet tomorrow to decide on gelatin versus cellulose

Submit status of global compensation: DCGI tells J&J

December 23, 2014 1:52 am

Despite two written requests by the state FDA, the request has not been approved in the last six months.

Pharma Inc calls for alignment with US rules

February 12, 2014 3:18 am

Over 25 per cent of the generics imported by the US come from India.

Govt mulls USFDA-like checks to keep MNC drug makers on toes

January 29, 2014 2:45 am

Move comes soon after US Food and Drug Administration (USFDA) banned Ranbaxy’s fourth unit at Toansa.

‘Bring DCGI on a par with other regulators’

January 31, 2012 2:27 am

Prof M K Bhan,Secretary,Department of Biotechnology,Government of India,on Monday called for a systematic and quantitative measurement of work to monitor bio-pharmaceutical products and drug trials.

DCGI: Cancel licences of those exporting banned malaria drug

April 27, 2011 12:51 am

The oral single drug formulation of Artemisinin,having potential to become resistant to malaria,has been withdrawn from India. However,some manufacturers continue to produce and export it as a mono therapy.

DCGI wants Health to ban diabetes drug

October 29, 2010 12:11 am

The Drug Controller General of India (DCGI) has proposed to the Health Ministry to ban Rosiglitazone.